Topic: Biology

Scientists found that blocking a cellular enzyme to protect against fatty liver disease may actually increase the risk of chronic liver damage and cancer as people age.

Researchers from the University of Adelaide have made a surprising discovery about a potential treatment for fatty liver disease. They found that shutting down an enzyme called Caspase-2 may not be helpful in the long run. In fact, it could raise the chances of developing chronic liver damage and cancer as people age.

Caspase-2 plays a crucial role in keeping liver cells genetically stable. It also helps regulate fat levels within the liver. Without this enzyme, liver cells can grow abnormally, leading to inflammation, scarring, and an increased risk of liver cancer.

The researchers used genetically modified mice to study this further. They found that mice without functional Caspase-2 developed chronic liver inflammation and characteristics of hepatitis-like liver disease, including scarring, oxidative damage, and a type of cell death linked to inflammation. As the animals aged, they were much more likely to develop liver cancer.

The findings suggest that targeting this pathway could have unintended consequences over time. This challenges the growing interest in Caspase-2 inhibitors as a treatment for fatty liver disease.

Liver disease continues to rise globally, driven by ageing populations, obesity, and metabolic conditions. In 2022 alone, liver cancer caused nearly 760,000 deaths worldwide, according to the World Cancer Research Fund.

Why It Matters

This study is important because it highlights the potential risks of a treatment that was previously thought to be beneficial for fatty liver disease. As India continues to grapple with the rising incidence of liver disease and cancer, it's essential to understand the long-term consequences of any treatment approach.

Key Facts

• Blocking Caspase-2 may increase the risk of chronic liver damage and cancer as people age.
• Caspase-2 helps keep liver cells genetically stable and regulates fat levels within the liver.
• Mice without functional Caspase-2 developed chronic liver inflammation, scarring, and an increased risk of liver cancer.

Key Terms

Polyploidy

A condition where liver cells have extra copies of genetic material

Implications

This study is important because it highlights the potential risks of a treatment that was previously thought to be beneficial for fatty liver disease. As India continues to grapple with the rising incidence of liver disease and cancer, it's essential to understand the long-term consequences of any treatment approach.